KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Other financing activities (2016 - 2020)

Evolent Health has reported Other financing activities over the past 6 years, most recently at $33.7 million for Q1 2020.

  • Quarterly results put Other financing activities at $33.7 million for Q1 2020, up 131.33% from a year ago — trailing twelve months through Mar 2020 was $36.9 million (up 425.28% YoY), and the annual figure for FY2019 was -$104.3 million, down 208.44%.
  • Other financing activities for Q1 2020 was $33.7 million at Evolent Health, up from -$104.9 million in the prior quarter.
  • Over the last five years, Other financing activities for EVH hit a ceiling of $108.1 million in Q2 2019 and a floor of -$107.5 million in Q1 2019.
  • Median Other financing activities over the past 5 years was $950000.0 (2016), compared with a mean of $2.1 million.
  • Biggest five-year swings in Other financing activities: soared 2319.33% in 2018 and later tumbled 209.07% in 2019.
  • Evolent Health's Other financing activities stood at $1.6 million in 2016, then skyrocketed by 1240.5% to $21.4 million in 2017, then skyrocketed by 348.31% to $96.2 million in 2018, then tumbled by 209.07% to -$104.9 million in 2019, then surged by 132.11% to $33.7 million in 2020.
  • The last three reported values for Other financing activities were $33.7 million (Q1 2020), -$104.9 million (Q4 2019), and -$1000.0 (Q3 2019) per Business Quant data.